The new edition of Dermatological Signs of Systemic Disease helps you identify a full range of common and rare systemic diseases early on so they can be managed as effectively as possible. Formerly titled Dermatological Signs of Internal Disease, it takes an evidence-based approach to diagnosis and treatment, offering dependable clinical recommendations that enable you to attain definitive diagnoses of internal diseases that manifest on the skin. Allows you to attain definitive diagnoses of internal diseases that manifest on the skin. Uses a consistent, user-friendly format for easy reference. Covers hot topics such as lupus erythematosus, dermatomyositis, autoinflammatory diseases, eosinophilic and neutrophilic dermatoses, and psoriasis therapies and co-morbidities. Highlights newer therapies and treatment options for most diseases. Includes over 500 full-color illustrations - 200 new to this edition - that provide the best possible representations of diseases as they appear in the clinic. Features more viewpoints from an expanded team of nationally recognized experts in their respective fields.
Now in a fully revised thirteenth edition, Andrews’ Diseases of the Skin remains your single-volume, must-have resource for core information in dermatology. From residency through clinical practice, this award-winning title ensures that you stay up to date with new tools and strategies for diagnosis and treatment, new entities and newly recognized diseases, and current uses for tried-and-true and newer medications. It’s the reference you’ll turn to again and again when faced with a clinical conundrum or therapeutically challenging skin disease. Utilizes a concise, clinically focused, user-friendly format that clearly covers the full range of common and rare skin diseases. Provides outstanding visual support with 1,340 illustrations – more than 500 new to this edition. Presents comprehensively updated information throughout, including new and unusual clinical presentations of syphilis, new diagnostic classifications and therapies for vascular anomalies, and an updated pediatric and genodermatosis review. Covers new and evolving treatments for inflammatory, neoplastic, and blistering skin diseases among others. New biologics and phosphodiesterase inhibitors for psoriasis and atopic dermatitis, JAK inhibitors for alopecia areata and vitiligo, immune checkpoint inhibitors for melanoma and rituximab for pemphigus are all covered. Features a revised and revamped cutaneous adverse drug reaction section, including novel eruptions from new and emerging chemotherapeutic agents and small molecule/targeted inhibitors. Discusses new and emerging viruses including Zika and human polyomaviruses.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.